Corium International Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.57 |
Market Cap |
$342.93 M |
Shares Outstanding |
36.25 M |
Public Float |
26.14 M |
Address |
235 Constitution Drive Menlo Park California 94025 United States |
Employees | - |
Website | http://www.coriumgroup.com |
Updated | 09/14/2018 |
Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. |